Simon Dumesnil

KTTA

Simon Dumesnil serves as Director at Pasithea Therapeutics Corp. (KTTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$25.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$25.0K

Companies Traded

KTTA

Active Period

Nov 2025

1 total trades

Most Recent

Buy KTTA

Nov 28, 2025 · $25.0K

Simon Dumesnil's Insider Trading at Pasithea Therapeutics Corp. (KTTA)

Buys

1 · $25.0K

Sells

0 · $0.00

Total Shares Bought

33,333

Total Shares Sold

KTTA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 28, 2025↗	Buy	33,333	$0.75	$25.0K	0

Related Insiders

Tiago Marques

Chief Executive Officer

KTTABuy · Nov 28, 2025

STEINMAN LAWRENCE

Director

KTTABuy · Nov 28, 2025

Explore More Insider Trading Data

KTTA Insider Trading Activity

View all insider trades at Pasithea Therapeutics Corp.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity